Regulating human stem cell research and therapy in low- and middle-income countries: Malaysian perspectives
Many “rising powers” such as India, China, Argentina, Singapore, and Brazil are investing in stem cell technology, joining the traditional leaders in the field, such as the UK, Germany, USA, and Japan. Malaysia is also entering this sector because of the potential medical and economic benefits that...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2018-01-01
|
| Series: | New Genetics and Society |
| Subjects: | |
| Online Access: | http://dx.doi.org/10.1080/14636778.2017.1415137 |
| _version_ | 1797681253741232128 |
|---|---|
| author | Mohammad Firdaus Bin Abdul Aziz Michael Morrison Jane Kaye |
| author_facet | Mohammad Firdaus Bin Abdul Aziz Michael Morrison Jane Kaye |
| author_sort | Mohammad Firdaus Bin Abdul Aziz |
| collection | DOAJ |
| description | Many “rising powers” such as India, China, Argentina, Singapore, and Brazil are investing in stem cell technology, joining the traditional leaders in the field, such as the UK, Germany, USA, and Japan. Malaysia is also entering this sector because of the potential medical and economic benefits that the use of stem cell technologies could provide. Like other countries, Malaysia faces the challenge of how to encourage scientific progress and innovation in an ethical manner while at the same time ensuring a safe and accessible market for regenerative therapies. This paper reports on the research findings of semi-structured interviews with local stakeholders to investigate how they perceived and evaluated the current regulatory framework for human stem cell research in Malaysia, and what might be at stake if the state continues with its current regulatory approach. |
| first_indexed | 2024-03-11T23:42:23Z |
| format | Article |
| id | doaj.art-a3dd86115eda45e9b775ec2881721060 |
| institution | Directory Open Access Journal |
| issn | 1463-6778 1469-9915 |
| language | English |
| last_indexed | 2024-03-11T23:42:23Z |
| publishDate | 2018-01-01 |
| publisher | Taylor & Francis Group |
| record_format | Article |
| series | New Genetics and Society |
| spelling | doaj.art-a3dd86115eda45e9b775ec28817210602023-09-19T15:22:17ZengTaylor & Francis GroupNew Genetics and Society1463-67781469-99152018-01-0137122010.1080/14636778.2017.14151371415137Regulating human stem cell research and therapy in low- and middle-income countries: Malaysian perspectivesMohammad Firdaus Bin Abdul Aziz0Michael Morrison1Jane Kaye2University of MalayaUniversity of MalayaUniversity of MalayaMany “rising powers” such as India, China, Argentina, Singapore, and Brazil are investing in stem cell technology, joining the traditional leaders in the field, such as the UK, Germany, USA, and Japan. Malaysia is also entering this sector because of the potential medical and economic benefits that the use of stem cell technologies could provide. Like other countries, Malaysia faces the challenge of how to encourage scientific progress and innovation in an ethical manner while at the same time ensuring a safe and accessible market for regenerative therapies. This paper reports on the research findings of semi-structured interviews with local stakeholders to investigate how they perceived and evaluated the current regulatory framework for human stem cell research in Malaysia, and what might be at stake if the state continues with its current regulatory approach.http://dx.doi.org/10.1080/14636778.2017.1415137human stem cell researchregulationstem cell ethics and policy |
| spellingShingle | Mohammad Firdaus Bin Abdul Aziz Michael Morrison Jane Kaye Regulating human stem cell research and therapy in low- and middle-income countries: Malaysian perspectives New Genetics and Society human stem cell research regulation stem cell ethics and policy |
| title | Regulating human stem cell research and therapy in low- and middle-income countries: Malaysian perspectives |
| title_full | Regulating human stem cell research and therapy in low- and middle-income countries: Malaysian perspectives |
| title_fullStr | Regulating human stem cell research and therapy in low- and middle-income countries: Malaysian perspectives |
| title_full_unstemmed | Regulating human stem cell research and therapy in low- and middle-income countries: Malaysian perspectives |
| title_short | Regulating human stem cell research and therapy in low- and middle-income countries: Malaysian perspectives |
| title_sort | regulating human stem cell research and therapy in low and middle income countries malaysian perspectives |
| topic | human stem cell research regulation stem cell ethics and policy |
| url | http://dx.doi.org/10.1080/14636778.2017.1415137 |
| work_keys_str_mv | AT mohammadfirdausbinabdulaziz regulatinghumanstemcellresearchandtherapyinlowandmiddleincomecountriesmalaysianperspectives AT michaelmorrison regulatinghumanstemcellresearchandtherapyinlowandmiddleincomecountriesmalaysianperspectives AT janekaye regulatinghumanstemcellresearchandtherapyinlowandmiddleincomecountriesmalaysianperspectives |